Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Orexigen Therapeutic (OREX)

1.16 0.18 (18.37%)

02-21 15:59

Open:

1

Pre. Close:

0.98

High:

1.19

Low:

0.99

Volume:

1,606,027

Market Cap:

22M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.192 - 1.197

1.197 - 1.202

Low:

0.98 - 0.984

0.984 - 0.989

Close:

1.172 - 1.18

1.18 - 1.189

Technical analysis  (as of: 2018-02-21 4:25:47 PM)

Overall:

      

Stoxline posted a STRONG BUY today, same as yesterday. This stock still seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 1.58     One year: 1.84

Support:

Support1:    Support2: 0.79

Resistance:

Resistance1: 1.35    Resistance2: 1.58

Pivot:

0.97

Moving Averages:

MA(5): 0.93     MA(20): 1.01

MA(100): 1.45     MA(250): 2.37

MACD:

MACD(12,26): -0.06     Signal(12,26,9): -0.08

%K %D:

%K(14,3): 54.10     %D(3): 28.43

RSI:

RSI(14): 61.31

52-Week:

High: 4.67  Low: 0.79  Change(%): -70.4

Average Vol(K):

3-Month: 28516  10-Days 54936

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
OREX has closed above the upper band by 0.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 28.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 21 Feb 2018 14:37:30 GMT
Orexigen Therapeutics, Inc. (OREX) Recent Ownership Changes

Tue, 14 Nov 2017 00:56:15 GMT
Orexigen Therapeutics' (OREX) CEO Michael Narachi on Q3 2017 Results ...

Mon, 13 Nov 2017 13:07:30 GMT
Orexigen Therapeutics Announces Commercialization and Distributorship ...

Mon, 27 Mar 2017 21:56:15 GMT
Orexigen Therapeutics Announces Commercialization and Distributorship ...

Tue, 25 Apr 2017 06:00:00 GMT
Orexigen Therapeutics Announces New Drug Submission for Contrave© in Canada

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

18.89

Shares Float (M)

18.53

% Held by Insiders

% Held by Institutions

38.10

Shares Short (K)

877

Shares Short Prior Month (K)

1190

Stock Financials

EPS

-10.510

EPS Est. Current Year

-9.370

EPS Est. Next Year

-5.590

EPS Est. Next Quarter

-1.960

Forward EPS

-5.188

Book Value (p.s.)

0.900

PEG Ratio

Profit Margin

Operating Margin

-209.79

Return on Assets (ttm)

-52.2

Return on Equity (ttm)

-2026.6

Qtrly Rev. Growth

170.0

Gross Profit (p.s.)

2.856

Sales Per Share

EBITDA (p.s.)

-6.978

Qtrly Earnings Growth

Operating Cash Flow (M)

-140.04

Levered Free Cash Flow (M)

66.27

atoplab.com

Valuation

P/E

-0.11

P/E Growth Ratio

0.20

P/BV

1.31

P/S

4449141.50

P/CF

-0.16

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-07-12

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.